Drug · DIN 02207648
APO-ACYCLOVIR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 22, 1997; first marketed August 22, 1997.
- Drug Identification Number (DIN)
- 02207648
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Acyclovir J05AB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACYCLOVIR | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 21, 1997: NOC 3258New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “apo-acyclovir”. A notice may cover another product or only some lots: read it to see what it covers.
- Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers)August 14, 2023 · Drugs · Contamination · Type I
- Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurityJuly 28, 2022 · Drugs · Contamination
Other DINs named APO-ACYCLOVIR
- DIN 02207621 · Marketed
- DIN 02207656 · Marketed